Found: 47
Select item for more details and to access through your institution.
Immune Checkpoint Inhibition in Gastro-Oesophageal Cancer.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 5, p. 272, doi. 10.1159/000489099
- By:
- Publication type:
- Article
Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 1, p. e2352830, doi. 10.1001/jamanetworkopen.2023.52830
- By:
- Publication type:
- Article
Systemic Chemotherapy Including Ramucirumab in Combination With Pressurized Intra-Peritoneal Aerosol Chemotherapy Is a Safe Treatment Option for Peritoneal Metastasis of Gastric Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.610572
- By:
- Publication type:
- Article
Recent Progress in the Treatment of Colorectal Cancer.
- Published in:
- Medizinische Klinik (Urban & Vogel), 2006, v. 101, n. 2, p. 114
- By:
- Publication type:
- Article
New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin.
- Published in:
- Chemotherapy (0009-3157), 2016, v. 62, n. 1, p. 62, doi. 10.1159/000443984
- By:
- Publication type:
- Article
Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 1, p. 152, doi. 10.1245/s10434-021-10508-x
- By:
- Publication type:
- Article
ASO Visual Abstract: Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin—A Single Center Observational Study.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Prognostic Relevance of Weight and Weight Loss during Multimodal Therapy for Oesophagogastric Tumours.
- Published in:
- Current Oncology, 2022, v. 29, n. 4, p. 2706, doi. 10.3390/curroncol29040221
- By:
- Publication type:
- Article
Immunotherapy in Squamous Cell Cancer of the Esophagus.
- Published in:
- Current Oncology, 2022, v. 29, n. 4, p. 2461, doi. 10.3390/curroncol29040200
- By:
- Publication type:
- Article
Impact of Postoperative Chemotherapy in Patients with Gastric/Gastroesophageal Adenocarcinoma Treated with Perioperative Chemotherapy.
- Published in:
- Current Oncology, 2022, v. 29, n. 3, p. 1983, doi. 10.3390/curroncol29030161
- By:
- Publication type:
- Article
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 1, p. 6, doi. 10.1007/s10120-023-01424-y
- By:
- Publication type:
- Article
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS).
- Published in:
- Gastric Cancer, 2022, v. 25, n. 3, p. 586, doi. 10.1007/s10120-021-01271-9
- By:
- Publication type:
- Article
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 197, doi. 10.1007/s10120-021-01227-z
- By:
- Publication type:
- Article
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 4, p. 970, doi. 10.1007/s10120-021-01156-x
- By:
- Publication type:
- Article
The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 6, p. 1226, doi. 10.1007/s10120-019-00969-1
- By:
- Publication type:
- Article
Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 4, p. 803, doi. 10.1007/s10120-018-00923-7
- By:
- Publication type:
- Article
High Impact of Histopathological Remission for Prognosis after Perioperative Chemotherapy with ECF and ECF-Like Regimens for Gastric and Gastroesophageal Adenocarcinoma.
- Published in:
- Oncology, 2015, v. 89, n. 2, p. 95, doi. 10.1159/000376550
- By:
- Publication type:
- Article
Indication of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer (Gastripec, Gastrichip).
- Published in:
- Visceral Medicine, 2022, v. 38, n. 2, p. 81, doi. 10.1159/000522604
- By:
- Publication type:
- Article
Immunotherapy in Esophagogastric Adenocarcinoma.
- Published in:
- Visceral Medicine, 2019, v. 35, n. 1, p. 12, doi. 10.1159/000497292
- By:
- Publication type:
- Article
Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 21, p. 1667, doi. 10.1093/jnci/djt269
- By:
- Publication type:
- Article
Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5937, doi. 10.1007/s00432-022-04459-3
- By:
- Publication type:
- Article
HER2 testing in gastric cancer: results of a German expert meeting.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 5, p. 835, doi. 10.1007/s00432-017-2374-x
- By:
- Publication type:
- Article
Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2‐Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
- Published in:
- Oncologist, 2020, v. 25, n. 8, p. e1181, doi. 10.1634/theoncologist.2020-0109
- By:
- Publication type:
- Article
Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: Results of a multicenter phase I/II study.
- Published in:
- Acta Oncologica, 2014, v. 53, n. 3, p. 392, doi. 10.3109/0284186X.2013.833346
- By:
- Publication type:
- Article
Peritonealkarzinose des Magenkarzinoms: Therapeutische Möglichkeiten bei Peritonealkarzinose des Magenkarzinoms.
- Published in:
- Der Chirurg, 2022, v. 93, n. 12, p. 1133, doi. 10.1007/s00104-022-01699-4
- By:
- Publication type:
- Article
Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil plus Folinic Acid in Combination with Mitomycin C for the Treatment of Advanced Gastric Cancer.
- Published in:
- Oncology, 2000, v. 59, n. 1, p. 14, doi. 10.1159/000012130
- By:
- Publication type:
- Article
A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiation.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-74701-w
- By:
- Publication type:
- Article
End-of-life care for immigrants in Germany. An epidemiological appraisal of Berlin.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182033
- By:
- Publication type:
- Article
Evaluation of a communication skills training to facilitate addressing palliative care related topics in advanced cancer patients: study protocol of a multicenter randomized controlled trial (PALLI-KOM).
- Published in:
- BMC Palliative Care, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12904-020-00568-3
- By:
- Publication type:
- Article
Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 12, p. 1273, doi. 10.1007/s00262-014-1596-x
- By:
- Publication type:
- Article
Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessment.
- Published in:
- Palliative Care & Social Practice, 2024, p. 1, doi. 10.1177/26323524241260424
- By:
- Publication type:
- Article
Frequency of Positive Familial Criteria in Patients with Adenocarcinoma of the Esophageal-Gastric Junction and Stomach: First Prospective Data in a Caucasian Cohort †.
- Published in:
- Cancers, 2022, v. 14, n. 15, p. 3590, doi. 10.3390/cancers14153590
- By:
- Publication type:
- Article
CT Body Composition of Sarcopenia and Sarcopenic Obesity: Predictors of Postoperative Complications and Survival in Patients with Locally Advanced Esophageal Adenocarcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2921, doi. 10.3390/cancers13122921
- By:
- Publication type:
- Article
Textbook Outcome after Gastrectomy for Gastric Cancer Is Associated with Improved Overall and Disease-Free Survival.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 16, p. 5419, doi. 10.3390/jcm12165419
- By:
- Publication type:
- Article
The Learning Curve for Hand-Assisted Laparoscopic Total Gastrectomy in Gastric Cancer Patients.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 22, p. 6841, doi. 10.3390/jcm11226841
- By:
- Publication type:
- Article
The Association between Neoadjuvant Radio-Chemotherapy and Prolonged Healing of Anastomotic Leakage after Esophageal Resection Treated with EndoVAC Therapy.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 16, p. 4773, doi. 10.3390/jcm11164773
- By:
- Publication type:
- Article
Efficacy of ramucirumab combination chemotherapy as second‐line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first‐line therapy.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 12, p. 2142, doi. 10.1002/ijc.34894
- By:
- Publication type:
- Article
Pazopanib with 5‐FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase‐II study—The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO‐STO‐0510.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 1007, doi. 10.1002/ijc.33864
- By:
- Publication type:
- Article
Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2‐positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 6, p. 1322, doi. 10.1002/ijc.33696
- By:
- Publication type:
- Article
Phase III randomized, double‐blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum‐containing regimen (RADPAC)
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 9, p. 2493, doi. 10.1002/ijc.33025
- By:
- Publication type:
- Article
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).
- Published in:
- 2020
- By:
- Publication type:
- journal article
High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.
- Published in:
- 2020
- By:
- Publication type:
- journal article
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association between oncologists' death anxiety and their end‐of‐life communication with advanced cancer patients.
- Published in:
- Psycho-Oncology, 2023, v. 32, n. 6, p. 923, doi. 10.1002/pon.6132
- By:
- Publication type:
- Article
Immune Checkpoint Inhibition in Oesophago-Gastric Carcinoma.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 2, p. 151, doi. 10.3390/ph14020151
- By:
- Publication type:
- Article
Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.
- Published in:
- 2016
- By:
- Publication type:
- journal article